{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:36:42Z","timestamp":1793320602151,"version":"4.5.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>With the increasing implementation of early lung cancer screening and the increasing emphasis on physical examinations, the early-stage lung cancer detection rate continues to rise. Visceral pleural invasion (VPI), which denotes the tumor\u2019s breach of the elastic layer or reaching the surface of the visceral pleura, stands as a pivotal factor that impacts the prognosis of patients with non-small cell lung cancer (NSCLC) and directly influences the pathological staging of early-stage cases. According to the latest 9th edition of the TNM staging system for NSCLC, even when the tumor diameter is less than 3 cm, the final T stage remains T2a if VPI is present. There is considerable controversy within the guidelines regarding treatment options for stage IB NSCLC, especially among patients exhibiting VPI. Moreover, the precise determination of VPI is important in guiding treatment selection and prognostic evaluation in individuals with NSCLC. This article aims to provide a comprehensive review of the current status and advancements in studies pertaining to stage IB NSCLC accompanied by VPI.<\/jats:p>","DOI":"10.3389\/fonc.2023.1310471","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:39:08Z","timestamp":1705293548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion"],"prefix":"10.3389","volume":"13","author":[{"given":"Zegang","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12151-6","article-title":"Globocan 2020 report on global cancer burden: challenges and opportunities for surgical oncologists","volume":"29","author":"Deo","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/jto.0000000000000559","article-title":"The iaslc lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the tnm classification for lung cancer","volume":"10","author":"Rami-Porta","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1010-7940(03)00119-2","article-title":"Prognostic value of visceral pleura invasion in non-small cell lung cancer","volume":"23","author":"Kang","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16476","article-title":"Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size \u2264 3cm","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/1759-7714.12412","article-title":"Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer","volume":"8","author":"Tian","year":"2017","journal-title":"Thorac Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jso.24677","article-title":"Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the seer registry","volume":"116","author":"Yang","year":"2017","journal-title":"J Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.48","article-title":"Pleura space anatomy","volume":"7","author":"Charalampidis","year":"2015","journal-title":"J Thorac Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-5231(05)70074-5","article-title":"Anatomy of the pleura","volume":"19","author":"Wang","year":"1998","journal-title":"Clin Chest Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2003.10.058","article-title":"Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance","volume":"77","author":"Osaki","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2003.11.017","article-title":"Visceral pleural invasion classification in non-small cell lung cancer: A proposal on the basis of outcome assessment","volume":"127","author":"Shimizu","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.11.008","article-title":"Prognostic significance of visceral pleural invasion in the forthcoming (Seventh) edition of tnm classification for lung cancer","volume":"65","author":"Shim","year":"2009","journal-title":"Lung Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31818e0d9f","article-title":"Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the tnm classification for lung cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151120","article-title":"Pleural tags on ct scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura","volume":"279","author":"Hsu","year":"2016","journal-title":"Radiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/rct.0000000000000439","article-title":"Multivariate analysis of pleural invasion of peripheral non-small cell lung cancer-based computed tomography features","volume":"40","author":"Qi","year":"2016","journal-title":"J Comput Assist Tomogr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07869-y","article-title":"Correlation between pleural tags on ct and visceral pleural invasion of peripheral lung cancer that does not appear touching the pleural surface","volume":"31","author":"Onoda","year":"2021","journal-title":"Eur Radiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.03.185","article-title":"Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm","volume":"10","author":"Deng","year":"2018","journal-title":"J Thorac Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-019-01101-x","article-title":"A risk scoring system for predicting visceral pleural invasion in non-small lung cancer patients","volume":"67","author":"Iizuka","year":"2019","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezx419","article-title":"Autofluorescence for the diagnosis of visceral pleural invasion in non-small-cell lung cancer","volume":"53","author":"Takizawa","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/112.6.777","article-title":"The diagnosis and significance of visceral pleural invasion in lung carcinoma","volume":"112","author":"Bunker","year":"1999","journal-title":"Histologic Predictors Role Elastic Stains Am J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.7754\/Clin.Lab.2020.200851","article-title":"Evaluating three elastic-fiber staining methods for detecting visceral pleural invasion in lung adenocarcinoma patients","volume":"67","author":"Xie","year":"2021","journal-title":"Clin Lab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.pap.0000151266.26814.02","article-title":"Visceral pleural invasion in lung cancer: recognizing histologic parameters that impact staging and prognosis","volume":"12","author":"Butnor","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31802ca413","article-title":"Impact of elastic staining on the staging of peripheral lung cancers","volume":"31","author":"Taube","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2011.10.006","article-title":"Are elastic stain and specialty sign out necessary to evaluate pleural invasion in lung cancers","volume":"16","author":"Jung","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/10668969221098089","article-title":"Clinical significance of dual-block elastic stain evaluating visceral pleural invasion in peripheral non-small cell lung cancer","volume":"31","author":"Li","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3935-0_32","article-title":"Common tumors","author":"Hammar","year":"1994","journal-title":"Pulmonary Pathol"},{"key":"B27","volume-title":"Ajcc cancer staging manual","author":"Frederick","year":"2002"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31819e7814","article-title":"The 7th edition of tnm in lung cancer: what now","volume":"4","author":"Goldstraw","year":"2009","journal-title":"J Thorac Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-009-9201-x","article-title":"A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancer","volume":"16","author":"Warth","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41598-017-01845-7","article-title":"Extent of visceral pleural invasion affects prognosis of resected non-small cell lung cancer: A meta-analysis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.11.021","article-title":"Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer","volume":"130","author":"Shimizu","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2020.100640","article-title":"Prognostic value of visceral pleural invasion in the stage pt(1-2)N(2)M(0) non-small cell lung cancer: A study based on the seer registry","volume":"45","author":"Zhang","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2008.04.117","article-title":"Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion","volume":"86","author":"Sakakura","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.04.059","article-title":"Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival","volume":"134","author":"Hung","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0394","article-title":"Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma \u2264 2 cm: A proposal to reclassify T1 lung adenocarcinoma","volume":"144","author":"Nitadori","year":"2013","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.08.004","article-title":"Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer","volume":"78","author":"Kudo","year":"2012","journal-title":"Lung Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31828632b8","article-title":"Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database","volume":"8","author":"Kawase","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.012","article-title":"Visceral pleural invasion impacts the prognosis of non-small cell lung cancer: A meta-analysis","volume":"42","author":"Liu","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.09.010","article-title":"Re-evaluation of the prognostic value of visceral pleura invasion in stage ib non-small cell lung cancer using the prospective multicenter acosog Z0030 trial data set","volume":"78","author":"Fibla","year":"2012","journal-title":"Lung Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jtho.2019.01.013","article-title":"Survival with parenchymal and pleural invasion of non-small cell lung cancers less than 30 mm","volume":"14","author":"Yip","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lungcan.2021.06.003","article-title":"The modification of T description according to visceral pleural invasion and tumor size from 3.1 Cm to 4.0 Cm in non-small cell lung cancer: A retrospective analysis based on the seer database","volume":"158","author":"Qi","year":"2021","journal-title":"Lung Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-023-00635-5","article-title":"Investigation of early-stage non-small cell lung cancer patients with different T2 descriptors: real word data from a large database","volume":"201","author":"Cai","year":"2023","journal-title":"Lung"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.902710","article-title":"Rethinking the selection of pathological T-classification for non-small-cell lung cancer in varying degrees of visceral pleural invasion: A seer-based study","volume":"9","author":"Fang","year":"2022","journal-title":"Front Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.02.009","article-title":"The eighth tnm classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures","volume":"118","author":"Sakakura","year":"2018","journal-title":"Lung Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.03.022","article-title":"Modification of pathologic T classification for non-small cell lung cancer with visceral pleural invasion: data from 1,055 cases of cancers \u2264 3 cm","volume":"160","author":"Liang","year":"2021","journal-title":"Chest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2022.04.009","article-title":"Non-small cell lung cancer surpassing the elastic layer should remain classified as pt2a","volume":"35","author":"Cai","year":"2023","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.21037\/atm-20-4971","article-title":"Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.08.002","article-title":"Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part-solid or solid lesions","volume":"14","author":"Fu","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5558-0","article-title":"Ct diagnosis of pleural and stromal invasion in Malignant subpleural pure ground-glass nodules: an exploratory study","volume":"29","author":"Zhao","year":"2019","journal-title":"Eur Radiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.04.084","article-title":"Visceral pleural invasion is not a significant prognostic factor in patients with a part-solid lung cancer","volume":"98","author":"Hattori","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-020-01470-8","article-title":"Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients","volume":"69","author":"Okada","year":"2021","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.05.90","article-title":"Visceral pleural invasion in lung adenocarcinoma \u22643 cm with ground-glass opacity: A clinical, pathological and radiological study","volume":"8","author":"Zhao","year":"2016","journal-title":"J Thorac Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.10.072","article-title":"Segment location and ground glass opacity ratio reliably predict node-negative status in lung cancer","volume":"109","author":"Zhang","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.06.129","article-title":"Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage ia non-small cell lung cancer","volume":"10","author":"Ding","year":"2018","journal-title":"J Thorac Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1990","article-title":"Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer","volume":"8","author":"Wo","year":"2019","journal-title":"Cancer Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/0300891618792463","article-title":"Level of pleural invasion effects on prognosis in lung cancer","volume":"105","author":"Tanju","year":"2019","journal-title":"Tumori"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and ii non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american college of chest physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington","year":"2013","journal-title":"Chest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(95)70427-2","article-title":"Incidence of local recurrence and second primary tumors in resected stage I lung cancer","volume":"109","author":"Martini","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.02.057","article-title":"Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage ia non-small cell lung cancer","volume":"146","author":"Koike","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12885-022-09634-w","article-title":"Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis","volume":"22","author":"Song","year":"2022","journal-title":"BMC Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.830470","article-title":"Treatment modality for stage ib peripheral non-small cell lung cancer with visceral pleural invasion and \u22643 cm in size","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21037\/jtd.2019.12.121","article-title":"Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size \u22642 cm accompanied by visceral pleural invasion: A seer population-based study","volume":"12","author":"Yu","year":"2020","journal-title":"J Thorac Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2023.06.020","article-title":"Segmentectomy vs lobectomy for early non-small cell lung cancer with visceral pleural invasion","author":"Mathey-Andrews","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-1995","article-title":"The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection","volume":"9","author":"Choi","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)60059-1","article-title":"Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data","volume":"375","author":"Arriagada","year":"2010","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv008","article-title":"Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer \u22654 cm in size: an seer-medicare analysis","volume":"26","author":"Malhotra","year":"2015","journal-title":"Ann Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-8-151","article-title":"Efficacy of platinum-based adjuvant chemotherapy in T2an0 stage ib non-small cell lung cancer","volume":"8","author":"Park","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.04.108","article-title":"Adjuvant chemotherapy for high-risk pathologic stage I non-small cell lung cancer","volume":"113","author":"Tsutani","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2801-7","article-title":"Should patients with stage ib non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the ajcc tnm staging system for stage ib patients","volume":"145","author":"Wang","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.03.184","article-title":"Efficacy of adjuvant chemotherapy for completely resected stage ib non-small cell lung cancer: A retrospective study","volume":"10","author":"Park","year":"2018","journal-title":"J Thorac Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14659","article-title":"Adjuvant chemotherapy in patients with recurrence after completely resected stage ib lung adenocarcinoma: propensity-matched analysis in a cohort of 147 recurrences","volume":"13","author":"Xu","year":"2022","journal-title":"Thorac Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lungcan.2019.04.024","article-title":"Propensity-matched analysis of adjuvant chemotherapy for completely resected stage ib non-small-cell lung cancer patients","volume":"133","author":"Li","year":"2019","journal-title":"Lung Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03276-w","article-title":"Effects of adjuvant chemotherapy on survival of patients with stage ib non-small cell lung cancer with visceral pleural invasion","volume":"146","author":"Xie","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1096683","article-title":"Adjuvant chemotherapy compared with observation in patients with T2an0 stage ib lung adenocarcinoma","volume":"13","author":"Lee","year":"2023","journal-title":"Front Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2354-y","article-title":"The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction","volume":"19","author":"Chang","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0204","article-title":"Prognostic significance of visceral pleural involvement in early-stage lung cancer","volume":"146","author":"Lakha","year":"2014","journal-title":"Chest"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2765","article-title":"The impact of visceral pleural invasion in node-negative non-small cell lung cancer: A systematic review and meta-analysis","volume":"148","author":"Jiang","year":"2015","journal-title":"Chest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.11.052","article-title":"Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer","volume":"99","author":"Huang","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2020.011","article-title":"Clinical efficacy of adjuvant chemotherapy in stage ib (< 4 cm) non-small cell lung cancer patients with high-risk factors","volume":"37","author":"Choi","year":"2022","journal-title":"Korean J Intern Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.784289","article-title":"Effect of adjuvant chemotherapy on survival of patients with 8th edition stage ib non-small cell lung cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.938195","article-title":"Adjuvant chemotherapy may improve long-term outcomes in stage ib non-small cell lung cancer patients with previous Malignancies: A propensity score-matched analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13685","article-title":"Influence of adjuvant chemotherapy on survival for patients with stage ib and iia non-small cell lung cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Thorac Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezab498","article-title":"Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival","volume":"62","author":"Wightman","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.05.022","article-title":"Adjuvant chemotherapy for patients with T2n0m0 nsclc","volume":"11","author":"Morgensztern","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lungcan.2021.08.017","article-title":"Prognostic relevance of pleural invasion for resected nsclc patients undergoing adjuvant treatments: A propensity score-matched analysis of seer database","volume":"161","author":"De Giglio","year":"2021","journal-title":"Lung Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100508","article-title":"Who are the real high-risk patients with pathological T2n0m0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy","volume":"7","author":"Hou","year":"2022","journal-title":"ESMO Open"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2552","article-title":"Prognostic significance of the extent of visceral pleural invasion in completely resected node-negative non-small cell lung cancer","volume":"142","author":"Hung","year":"2012","journal-title":"Chest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2217\/fon.13.160","article-title":"Prognostic and predictive markers for personalized adjuvant therapy for non-small-cell lung cancer patients","volume":"9","author":"Gadgeel","year":"2013","journal-title":"Future Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21037\/tlcr-21-1038","article-title":"A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage ib non-small cell lung cancer","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.851276","article-title":"Ground glass opacity and adjuvant chemotherapy in pathological stage ib-iia lung adenocarcinoma","volume":"12","author":"Zhai","year":"2022","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-21-1174","article-title":"The clinical prognostic factors of patients with stage ib lung adenocarcinoma","volume":"10","author":"Sui","year":"2021","journal-title":"Transl Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1177\/10732748231177541","article-title":"A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage ib non-small cell lung cancer","volume":"30","author":"Song","year":"2023","journal-title":"Cancer Control"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09362-0","article-title":"Survival nomogram for stage ib non-small-cell lung cancer patients, based on the seer database and an external validation cohort","volume":"28","author":"Zuo","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8816860","article-title":"Nomogram for predicting the relationship between the extent of visceral pleural invasion and survival in non-small-cell lung cancer","volume":"2021","author":"Wang","year":"2021","journal-title":"Can Respir J"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07366-z","article-title":"Adjuvant chemotherapy candidates in stage I lung adenocarcinomas following complete lobectomy","volume":"26","author":"Qian","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000004780","article-title":"Clinical significance of a circulating tumor cell-based classifier in stage ib lung adenocarcinoma: A multicenter, cohort study","volume":"277","author":"Ren","year":"2023","journal-title":"Ann Surg"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8052752","article-title":"Overall survival analyses following adjuvant chemotherapy or nonadjuvant chemotherapy in patients with stage ib non-small-cell lung cancer","volume":"2021","author":"Tu","year":"2021","journal-title":"J Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected egfr-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101839","article-title":"Adjuvant icotinib versus observation in patients with completely resected egfr-mutated stage ib nsclc (Gasto1003, corin): A randomised, open-label, phase 2 trial","volume":"57","author":"Ou","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage ib-iiia non-small-cell lung cancer (Impower010): A randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage ib-iiia non-small-cell lung cancer (Pearls\/keynote-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00014109","article-title":"Prognostic factors in pathological stage ib nonsmall cell lung cancer greater than 3 cm","volume":"36","author":"Hung","year":"2010","journal-title":"Eur Respir J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1759-7714.12424","article-title":"Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer","volume":"8","author":"Seok","year":"2017","journal-title":"Thorac Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyt039","article-title":"Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma","volume":"43","author":"Oyama","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu515","article-title":"Influence of visceral pleural invasion on survival in completely resected non-small-cell lung cancer","volume":"48","author":"Adachi","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.03.085","article-title":"Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size","volume":"95","author":"David","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.01.022","article-title":"The location of visceral pleural invasion in stage ib patients with non-small cell lung cancer: comparison and prognosis","volume":"49","author":"Ren","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-1840","article-title":"The prognosis of stage I non-small cell lung cancer with visceral pleural invasion and whole pleural adhesion after video-assisted thoracoscopic lobectomy: A single center retrospective study","volume":"12","author":"Moon","year":"2020","journal-title":"J Thorac Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5561-5","article-title":"Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer","volume":"29","author":"Ahn","year":"2019","journal-title":"Eur Radiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1310471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:39:13Z","timestamp":1705293553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1310471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":113,"alternative-id":["10.3389\/fonc.2023.1310471"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1310471","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1310471"}}